Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: APG-2449 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of APG-2449 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, esophageal…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors [Phase 1, Phase 2]
TAK-853 is being studied in adults with folate receptor alpha–positive advanced ovarian cancer and other solid tumors in Phase 1/Phase 2 tri…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Exercise Preconditioning in Ovarian Cancer [NA]
A clinical trial update for NCT05029154 investigating exercise preconditioning in ovarian cancer indicates the study has been terminated. Th…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This document reports the termination of a Phase 1/2 trial of AVB-S6-500 in combination with durvalumab for platinum-resistant or recurrent …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer [Phase 2]
Phase 2 European trial evaluating enhanced DNA repair inhibition in ovarian cancer has completed enrollment and posted results. The study al…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating a biomarker-driven targeted therapy for recurrent platinum-resistant epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Doxil/Caelyx BE Study [Phase 1]
Phase 1 bioequivalence study completion for Doxil/Caelyx in ovarian cancer, Kaposi sarcoma, multiple myeloma, and metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Interventions to Decrease Financial Toxicity [NA]
A completed clinical trial evaluating interventions to reduce financial toxicity in cancer care. The study was sponsored by the University o…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]
A Phase Ib safety study of Selinexor (KPT-330) in combination with standard chemotherapy or immunotherapy agents for patients with advanced …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer [Phase 1]
Phase 1 trial evaluating durvalumab and tremelimumab with radiotherapy in recurrent or metastatic gynecologic cancers has been terminated; n…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project [NA]
The GRACE Project, a Rutgers-led study on genetic risk assessment for cancer education and empowerment in breast and ovarian cancer, has com…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update reports termination of the NM21-1480 study in adults with advanced solid tumors, including non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer [Phase 1]
A Phase 1 trial of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis [Phase 1]
Phase 1 study evaluating nivolumab with or without ipilimumab in patients with recurrent or high-grade gynecologic cancers and metastatic pe…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients [NA]
A completed clinical trial evaluated post-operative intravenous ketorolac for GTPase inhibition in ovarian cancer patients. The study also i…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients. [Phase 4]
A Phase 4 study investigating relationships between clinical, biological, and pharmacokinetic metrics and toxicities in ovarian cancer patie…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of MNPR-101-PCTA-177Lu in solid tumors is currently recruiting across multiple cancer indications.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: IOTA Ultrasound Criteria and Serum CA 125 for Ovarian Malignancy Detection
A completed trial evaluating IOTA ultrasound criteria combined with serum CA-125 for detecting ovarian malignancy. The study is sponsored by…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer [Phase 1]
Phase 1 trial testing a combination of tamoxifen and SUBA-itraconazole for ovarian cancer; the study is listed as active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer [Phase 2]
A Phase II clinical trial is evaluating the combination of utidelone and fruquintinib for platinum-resistant recurrent ovarian cancer; the s…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Continued Access to RXDX-105 [Phase 1]
This clinical trial update concerns continued access to RXDX-105 in a Phase 1 study for non-small cell lung cancer and ovarian cancer, inclu…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer [Phase 2, Phase 3]
Results from a Phase 2/3 trial evaluating the combination of cediranib and olaparib versus each drug alone or chemotherapy in recurrent plat…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer [Phase 2, Phase 3]
Phase 2/3 trial updating the combination of cediranib and olaparib versus each drug alone or other chemotherapy in recurrent platinum-resist…